Compare SMTI & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMTI | GNE |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 359.1M |
| IPO Year | 2008 | 2011 |
| Metric | SMTI | GNE |
|---|---|---|
| Price | $34.00 | $14.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $34.00 | $16.00 |
| AVG Volume (30 Days) | ★ 399.7K | 61.5K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 95.65 |
| EPS | N/A | ★ 0.54 |
| Revenue | $15,586,976.00 | ★ $425,202,000.00 |
| Revenue This Year | $17.31 | $17.49 |
| Revenue Next Year | $12.48 | $7.07 |
| P/E Ratio | ★ N/A | $26.93 |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $12.69 |
| 52 Week High | $35.70 | $16.28 |
| Indicator | SMTI | GNE |
|---|---|---|
| Relative Strength Index (RSI) | 80.05 | 53.14 |
| Support Level | $33.68 | $13.45 |
| Resistance Level | $34.33 | $14.76 |
| Average True Range (ATR) | 0.61 | 0.38 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 96.27 | 70.08 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.